Uncomplicating the futureSM
 
Search

Healthcare Professionals

    Print page  

Adhesions and Your OBGYN Practice

Uterus adhesions
Dense adhesions to the uterus

Adhesions are a common consequence of pelvic surgery, forming after 46%–65% of primary C-sections1,2,3 and after up to 95% of gynecologic laparotomies.4 Adhesions can lead to serious complications for patients, including infertility4, chronic pelvic pain5, and small bowel obstruction.6

Adhesions also complicate and prolong future surgeries by making it difficult to identify, reach, and separate tissues including the uterus, tubes, and ovaries.7 Adhesions can also limit and complicate future treatment options, including intraperitoneal chemotherapy7, radiotherapy8, and laparoscopy.7

Adhesions account for up to:

  • 40% of infertility cases4
  • 48% of chronic pelvic pain cases9
  • 75% of small bowel obstructions10

SEPRAFILM® Adhesion Barrier is proven to help prevent postoperative adhesions.11

SEPRAFILM can be applied during the following open procedures11:

  • C-Section (Learn more, including application techniques)
  • Hysterectomy and Myomectomy (Learn more, including application techniques) 
  • Pelvic floor resection
  • Exploratory laparotomy
  • Adhesiolyisis
  • Adnexal procedures

12

1. Lyell DJ, Caughey AB, Hu E, Daniels K. Peritoneal closure at primary Cesarean delivery and adhesions. Obstet Gynecol. 2005;106:275-80.
 
2. Morales KJ, Gordon MC, Bates GW Jr. Postcesarean delivery adhesions associated with delayed delivery of infant. Am J Obstet Gynecol. 2007;196:461.e1-461.e6.
 
3. Fushiki H, Ikoma T, Kobayashi H, Yoshimoto H. Efficacy of SEPRAFILM as an Adhesion Barrier in Cesarean Sections. Obstetric and Gynecological Treatment [Japanese]. 2005;91(5):557-561.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
4. DiZerega GS.  Peritoneal repair and postsurgical adhesion formation. In: Management of Common Problems in Obstetrics & Gynecology. Mishell DR, Goodwin Murphy T, Brenner PF, eds. Malden, MA: Blackwell Publishing; 2002: 267-271.
 
5. Keltz MD, Gera PS, Olive DL.  Prospective randomized trial of right-sided paracolic adhesiolysis for chronic pelvic pain. JSLS. 2006;10(4):443-446.
 
6. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al.  Adhesion-related hospital readmissions after abdominal and pelvic surgery:  a retrospective cohort study. Lancet1999;353(9163):1476-1480.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
7. Nichols DH, Clarke-Pearson DL, eds. Gynecologic, Obstetric, and Related Surgery. 2nd ed. St. Louis, MO: Mosby, Inc; 1993.
 
8. Eifel PF.  Radiation therapy. In: Berek JS, Hacker NF, eds. Practical Gynecologic Oncology, 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005: 119-161.
 
9. Stovall TG, Elder RF, Ling FW. Predictors of pelvic adhesions. J Reprod Med. 1989;34:345-348.
 
10. Scovill WA. Small bowel obstruction. In: Cameron JL, ed. Current Therapy in Surgery. St Louis, MO: Mosby Yearbook Medical Publishers, Inc; 1995:100-104.
 
11. SEPRAFILM Prescribing Information. Cambridge, MA: Genzyme Biosurgery; 2007
 
11. SEPRAFILM Prescribing Information. Cambridge, MA: Genzyme Biosurgery; 2007
 
12. Makoha FW, Felimban HM, Fathuddien MA, Roomi F, Ghabra T. Multiple cesarean section morbidity. Int J Gynecol Obstet. 2004;87:227-232.
 

 

4 Section Thumbnail Introducing Seprafilm 4-Section

Packaged to improve exchange in the OR, Seprafilm 4-Section—four 3" × 2.5" precut sheets—provides the same overall coverage as the original 5" × 6" Seprafilm Adhesion Barrier.
Learn more

 

Adhesions and abdominopelvic surgery Adhesions and abdominopelvic surgery

Postoperative adhesions present a number of risks to patients undergoing a total abdominal hysterectomy, including chronic pelvic pain and small bowel obstruction.5,6 In a myomectomy, where the primary goal is restoration of fertility, adhesions are also of particular concern.4
Learn more

 

 

Adhesions – A prevalent risk in C-sections? Adhesions – A prevalent risk in C-sections?

Share your thoughts and register for a complimentary $25 Pharma card. Your expertise is valued.
Start now

 

Indication

Seprafilm® Adhesion Barrier is indicated for the reduction of post-surgical adhesions in patients undergoing abdominal or pelvic laparotomy.

Important Safety Information

Seprafilm should not be wrapped around an intestinal anastomosis as such usage may result in increased anastomotic leak related events, such as abscess or peritonitis. The safety and effectiveness of Seprafilm has not been established in combination with other adhesion prevention products and/or in surgical procedures not within the abdominopelvic cavity. The safety and effectiveness of Seprafilm has also not been evaluated in cases of pregnancy, malignancy, or frank infection. The type and frequency of adverse events reported are consistent with events typically seen following abdominopelvic surgery when used as directed.

Please see full prescribing information.

Terms and Conditions of Use | Privacy Policy | Contact Us | This site is intended for United States residents only © 2002-2012 Genzyme Corporation. All rights reserved. Seprafilm and Genzyme are registered trademarks of Genzyme Corporation. genzyme logo